Global Oxaliplatin Sales Market Report 2023

Global Oxaliplatin Sales Market Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxaliplatin Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 Mannitol
1.2.3 Glucose Solution
1.2.4 Lactose Solution
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oxaliplatin Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Colorectal Cancer
1.3.3 Stomach Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oxaliplatin Market Perspective (2018-2029)
2.2 Global Oxaliplatin Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Oxaliplatin Revenue Market Share by Region (2018-2023)
2.4 Global Oxaliplatin Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Oxaliplatin Estimates and Projections (2018-2029)
2.5.2 Europe Oxaliplatin Estimates and Projections (2018-2029)
2.5.3 China Oxaliplatin Estimates and Projections (2018-2029)
2.5.4 Japan Oxaliplatin Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Oxaliplatin Estimates and Projections (2018-2029)
2.5.6 India Oxaliplatin Estimates and Projections (2018-2029)
3 Global Oxaliplatin Competition Landscape by Players
3.1 Global Top Oxaliplatin Players by Revenue (2018-2023)
3.1.1 Global Top Oxaliplatin Players by Revenue (2018-2023)
3.1.2 Global Oxaliplatin Revenue Market Share by Players (2018-2023)
3.2 Global Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oxaliplatin Revenue
3.4 Global Oxaliplatin Market Concentration Ratio
3.4.1 Global Oxaliplatin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxaliplatin Revenue in 2022
3.5 Oxaliplatin Key Players Head office and Area Served
3.6 Key Players Oxaliplatin Product Solution and Service
3.7 Date of Enter into Oxaliplatin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxaliplatin Breakdown Data by Type
4.1 Global Oxaliplatin Historic Market Size by Type (2018-2023)
4.2 Global Oxaliplatin Forecasted Market Size by Type (2024-2029)
5 Oxaliplatin Breakdown Data by Application
5.1 Global Oxaliplatin Historic Market Size by Application (2018-2023)
5.2 Global Oxaliplatin Forecasted Market Size by Application (2024-2029)
6 United States Oxaliplatin Market Facts & Figures
6.1 United States Oxaliplatin Revenue by Company (2018-2023)
6.2 United States Oxaliplatin Market Size by Type
6.2.1 United States Oxaliplatin Market Size by Type (2018-2023)
6.2.2 United States Oxaliplatin Market Size by Type (2024-2029)
6.2.3 United States Oxaliplatin Market Share by Type (2018-2029)
6.3 United States Oxaliplatin Market Size by Application
6.3.1 United States Oxaliplatin Market Size by Application (2018-2023)
6.3.2 United States Oxaliplatin Market Size by Application (2024-2029)
6.3.3 United States Oxaliplatin Market Share by Application (2018-2029)
7 Europe Oxaliplatin Market Facts & Figures
7.1 Europe Oxaliplatin Revenue by Company (2018-2023)
7.2 Europe Oxaliplatin Market Size by Type
7.2.1 Europe Oxaliplatin Market Size by Type (2018-2023)
7.2.2 Europe Oxaliplatin Market Size by Type (2024-2029)
7.2.3 Europe Oxaliplatin Market Share by Type (2018-2029)
7.3 Europe Oxaliplatin Market Size by Application
7.3.1 Europe Oxaliplatin Market Size by Application (2018-2023)
7.3.2 Europe Oxaliplatin Market Size by Application (2024-2029)
7.3.3 Europe Oxaliplatin Market Share by Application (2018-2029)
8 China Oxaliplatin Market Facts & Figures
8.1 China Oxaliplatin Revenue by Company (2018-2023)
8.2 China Oxaliplatin Market Size by Type
8.2.1 China Oxaliplatin Market Size by Type (2018-2023)
8.2.2 China Oxaliplatin Market Size by Type (2024-2029)
8.2.3 China Oxaliplatin Market Share by Type (2018-2029)
8.3 China Oxaliplatin Market Size by Application
8.3.1 China Oxaliplatin Market Size by Application (2018-2023)
8.3.2 China Oxaliplatin Market Size by Application (2024-2029)
8.3.3 China Oxaliplatin Market Share by Application (2018-2029)
9 Japan Oxaliplatin Market Facts & Figures
9.1 Japan Oxaliplatin Revenue by Company (2018-2023)
9.2 Japan Oxaliplatin Market Size by Type
9.2.1 Japan Oxaliplatin Market Size by Type (2018-2023)
9.2.2 Japan Oxaliplatin Market Size by Type (2024-2029)
9.2.3 Japan Oxaliplatin Market Share by Type (2018-2029)
9.3 Japan Oxaliplatin Market Size by Application
9.3.1 Japan Oxaliplatin Market Size by Application (2018-2023)
9.3.2 Japan Oxaliplatin Market Size by Application (2024-2029)
9.3.3 Japan Oxaliplatin Market Share by Application (2018-2029)
10 Southeast Asia Oxaliplatin Market Facts & Figures
10.1 Southeast Asia Oxaliplatin Revenue by Company (2018-2023)
10.2 Southeast Asia Oxaliplatin Market Size by Type
10.2.1 Southeast Asia Oxaliplatin Market Size by Type (2018-2023)
10.2.2 Southeast Asia Oxaliplatin Market Size by Type (2024-2029)
10.2.3 Southeast Asia Oxaliplatin Market Share by Type (2018-2029)
10.3 Southeast Asia Oxaliplatin Market Size by Application
10.3.1 Southeast Asia Oxaliplatin Market Size by Application (2018-2023)
10.3.2 Southeast Asia Oxaliplatin Market Size by Application (2024-2029)
10.3.3 Southeast Asia Oxaliplatin Market Share by Application (2018-2029)
11 India Oxaliplatin Market Facts & Figures
11.1 India Oxaliplatin Revenue by Company (2018-2023)
11.2 India Oxaliplatin Market Size by Type
11.2.1 India Oxaliplatin Market Size by Type (2018-2023)
11.2.2 India Oxaliplatin Market Size by Type (2024-2029)
11.2.3 India Oxaliplatin Market Share by Type (2018-2029)
11.3 India Oxaliplatin Market Size by Application
11.3.1 India Oxaliplatin Market Size by Application (2018-2023)
11.3.2 India Oxaliplatin Market Size by Application (2024-2029)
11.3.3 India Oxaliplatin Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Company Details
12.1.2 Sanofi-Aventis Business Overview
12.1.3 Sanofi-Aventis Oxaliplatin Introduction
12.1.4 Sanofi-Aventis Revenue in Oxaliplatin Business (2018-2023)
12.1.5 Sanofi-Aventis Recent Development
12.2 Yakult honsha
12.2.1 Yakult honsha Company Details
12.2.2 Yakult honsha Business Overview
12.2.3 Yakult honsha Oxaliplatin Introduction
12.2.4 Yakult honsha Revenue in Oxaliplatin Business (2018-2023)
12.2.5 Yakult honsha Recent Development
12.3 Dr Reddy's laboratories
12.3.1 Dr Reddy's laboratories Company Details
12.3.2 Dr Reddy's laboratories Business Overview
12.3.3 Dr Reddy's laboratories Oxaliplatin Introduction
12.3.4 Dr Reddy's laboratories Revenue in Oxaliplatin Business (2018-2023)
12.3.5 Dr Reddy's laboratories Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Company Details
12.4.2 Sun Pharmaceutical Business Overview
12.4.3 Sun Pharmaceutical Oxaliplatin Introduction
12.4.4 Sun Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.4.5 Sun Pharmaceutical Recent Development
12.5 Teva
12.5.1 Teva Company Details
12.5.2 Teva Business Overview
12.5.3 Teva Oxaliplatin Introduction
12.5.4 Teva Revenue in Oxaliplatin Business (2018-2023)
12.5.5 Teva Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Company Details
12.6.2 Fresenius Kabi Business Overview
12.6.3 Fresenius Kabi Oxaliplatin Introduction
12.6.4 Fresenius Kabi Revenue in Oxaliplatin Business (2018-2023)
12.6.5 Fresenius Kabi Recent Development
12.7 Hospira
12.7.1 Hospira Company Details
12.7.2 Hospira Business Overview
12.7.3 Hospira Oxaliplatin Introduction
12.7.4 Hospira Revenue in Oxaliplatin Business (2018-2023)
12.7.5 Hospira Recent Development
12.8 Mylan
12.8.1 Mylan Company Details
12.8.2 Mylan Business Overview
12.8.3 Mylan Oxaliplatin Introduction
12.8.4 Mylan Revenue in Oxaliplatin Business (2018-2023)
12.8.5 Mylan Recent Development
12.9 Jiangsu Hengrui Medicine
12.9.1 Jiangsu Hengrui Medicine Company Details
12.9.2 Jiangsu Hengrui Medicine Business Overview
12.9.3 Jiangsu Hengrui Medicine Oxaliplatin Introduction
12.9.4 Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2018-2023)
12.9.5 Jiangsu Hengrui Medicine Recent Development
12.10 Nanjing Pharmaceutical Factory
12.10.1 Nanjing Pharmaceutical Factory Company Details
12.10.2 Nanjing Pharmaceutical Factory Business Overview
12.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Introduction
12.10.4 Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2018-2023)
12.10.5 Nanjing Pharmaceutical Factory Recent Development
12.11 Jiangsu Aosaikang Pharmaceutical
12.11.1 Jiangsu Aosaikang Pharmaceutical Company Details
12.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
12.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Introduction
12.11.4 Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.11.5 Jiangsu Aosaikang Pharmaceutical Recent Development
12.12 Qilu Pharmaceutical
12.12.1 Qilu Pharmaceutical Company Details
12.12.2 Qilu Pharmaceutical Business Overview
12.12.3 Qilu Pharmaceutical Oxaliplatin Introduction
12.12.4 Qilu Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.12.5 Qilu Pharmaceutical Recent Development
12.13 Hisun Pharmaceutical
12.13.1 Hisun Pharmaceutical Company Details
12.13.2 Hisun Pharmaceutical Business Overview
12.13.3 Hisun Pharmaceutical Oxaliplatin Introduction
12.13.4 Hisun Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.13.5 Hisun Pharmaceutical Recent Development
12.14 Lunan Pharmaceutical
12.14.1 Lunan Pharmaceutical Company Details
12.14.2 Lunan Pharmaceutical Business Overview
12.14.3 Lunan Pharmaceutical Oxaliplatin Introduction
12.14.4 Lunan Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.14.5 Lunan Pharmaceutical Recent Development
12.15 Luoxin
12.15.1 Luoxin Company Details
12.15.2 Luoxin Business Overview
12.15.3 Luoxin Oxaliplatin Introduction
12.15.4 Luoxin Revenue in Oxaliplatin Business (2018-2023)
12.15.5 Luoxin Recent Development
12.16 Halfsky Pharmacy
12.16.1 Halfsky Pharmacy Company Details
12.16.2 Halfsky Pharmacy Business Overview
12.16.3 Halfsky Pharmacy Oxaliplatin Introduction
12.16.4 Halfsky Pharmacy Revenue in Oxaliplatin Business (2018-2023)
12.16.5 Halfsky Pharmacy Recent Development
12.17 YRPG
12.17.1 YRPG Company Details
12.17.2 YRPG Business Overview
12.17.3 YRPG Oxaliplatin Introduction
12.17.4 YRPG Revenue in Oxaliplatin Business (2018-2023)
12.17.5 YRPG Recent Development
12.18 Hainan Jinrui Pharmaceutical
12.18.1 Hainan Jinrui Pharmaceutical Company Details
12.18.2 Hainan Jinrui Pharmaceutical Business Overview
12.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Introduction
12.18.4 Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.18.5 Hainan Jinrui Pharmaceutical Recent Development
12.19 Jari Pharmaceutical
12.19.1 Jari Pharmaceutical Company Details
12.19.2 Jari Pharmaceutical Business Overview
12.19.3 Jari Pharmaceutical Oxaliplatin Introduction
12.19.4 Jari Pharmaceutical Revenue in Oxaliplatin Business (2018-2023)
12.19.5 Jari Pharmaceutical Recent Development
12.20 Chiatai Tianqing
12.20.1 Chiatai Tianqing Company Details
12.20.2 Chiatai Tianqing Business Overview
12.20.3 Chiatai Tianqing Oxaliplatin Introduction
12.20.4 Chiatai Tianqing Revenue in Oxaliplatin Business (2018-2023)
12.20.5 Chiatai Tianqing Recent Development
13 Market Dynamics
13.1 Oxaliplatin Industry Trends
13.2 Oxaliplatin Market Drivers
13.3 Oxaliplatin Market Challenges
13.4 Oxaliplatin Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer
List of Tables
Table 1. Global Oxaliplatin Market Size Growth Rate by Type (US$ Million): (2018 VS 2022 VS 2029)
Table 2. Major Players of Mannitol
Table 3. Major Players of Glucose Solution
Table 4. Key Players of Lactose Solution
Table 5. Key Players of Others
Table 6. Global Oxaliplatin Market Size Growth by Application (2018 VS 2022 VS 2029)
Table 7. Global Oxaliplatin Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029
Table 8. Global Oxaliplatin Revenue (US$ Million) Market Share by Region (2018-2023))
Table 9. Global Oxaliplatin Revenue Share by Region (2018-2023)
Table 10. Global Oxaliplatin Revenue (US$ Million) Forecast by Region (2024-2029)
Table 11. Global Oxaliplatin Revenue Share Forecast by Region (2024-2029)
Table 12. Global Oxaliplatin Revenue by Players (2018-2023) & (US$ Million)
Table 13. Global Oxaliplatin Revenue Share by Players (2018-2023)
Table 14. Global Oxaliplatin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaliplatin as of 2022)
Table 15. Ranking of Global Top Oxaliplatin Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Oxaliplatin Revenue (CR5 and HHI) & (2018-2023)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Oxaliplatin Product Solution and Service
Table 19. Date of Enter into Oxaliplatin Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 22. Global Oxaliplatin Revenue Market Share by Type (2018-2023)
Table 23. Global Oxaliplatin Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 24. Global Oxaliplatin Revenue Market Share by Type (2024-2029)
Table 25. Global Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 26. Global Oxaliplatin Revenue Market Share by Application (2018-2023)
Table 27. Global Oxaliplatin Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 28. Global Oxaliplatin Revenue Market Share by Application (2024-2029)
Table 29. United States Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 30. United States Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 31. United States Oxaliplatin Market Size by Type (2018-2023) & (MT)
Table 32. United States Oxaliplatin Market Size by Type (2024-2029) & (MT)
Table 33. United States Oxaliplatin Market Size by Application (2018-2023) & (MT)
Table 34. United States Oxaliplatin Market Size by Application (2024-2029) & (MT)
Table 35. Europe Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 36. Europe Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 37. Europe Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 38. Europe Oxaliplatin Market Size by Type (2024-2029) & (US$ Million)
Table 39. Europe Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 40. Europe Oxaliplatin Market Size by Application (2024-2029) & (US$ Million)
Table 41. China Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 42. China Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 43. China Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 44. China Oxaliplatin Market Size by Type (2024-2029) & (US$ Million)
Table 45. China Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 46. China Oxaliplatin Market Size by Application (2024-2029) & (US$ Million)
Table 47. Japan Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 48. Japan Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 49. Japan Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 50. Japan Oxaliplatin Market Size by Type (2024-2029) & (US$ Million)
Table 51. Japan Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 52. Japan Oxaliplatin Market Size by Application (2024-2029) & (US$ Million)
Table 53. Southeast Asia Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 54. Southeast Asia Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 55. Southeast Asia Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 56. Southeast Asia Oxaliplatin Market Size by Type (2024-2029) & (US$ Million)
Table 57. Southeast Asia Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 58. Southeast Asia Oxaliplatin Market Size by Application (2024-2029) & (US$ Million)
Table 59. India Oxaliplatin Revenue by Company (2018-2023) & (US$ Million)
Table 60. India Oxaliplatin Revenue Market Share by Company (2018-2023)
Table 61. India Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
Table 62. India Oxaliplatin Market Size by Type (2024-2029) & (US$ Million)
Table 63. India Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
Table 64. India Oxaliplatin Market Size by Application (2024-2029) & (US$ Million)
Table 65. Sanofi-Aventis Company Details
Table 66. Sanofi-Aventis Description and Business Overview
Table 67. Sanofi-Aventis Oxaliplatin Product
Table 68. Sanofi-Aventis Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 69. Sanofi-Aventis Recent Development
Table 70. Yakult honsha Company Details
Table 71. Yakult honsha Description and Business Overview
Table 72. Yakult honsha Oxaliplatin Product
Table 73. Yakult honsha Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 74. Yakult honsha Recent Development
Table 75. Dr Reddy's laboratories Company Details
Table 76. Dr Reddy's laboratories Description and Business Overview
Table 77. Dr Reddy's laboratories Oxaliplatin Product
Table 78. Dr Reddy's laboratories Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 79. Dr Reddy's laboratories Recent Development
Table 80. Sun Pharmaceutical Company Details
Table 81. Sun Pharmaceutical Description and Business Overview
Table 82. Sun Pharmaceutical Oxaliplatin Product
Table 83. Sun Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 84. Sun Pharmaceutical Recent Development
Table 85. Teva Company Details
Table 86. Teva Description and Business Overview
Table 87. Teva Oxaliplatin Product
Table 88. Teva Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 89. Teva Recent Development
Table 90. Fresenius Kabi Company Details
Table 91. Fresenius Kabi Description and Business Overview
Table 92. Fresenius Kabi Oxaliplatin Product
Table 93. Fresenius Kabi Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 94. Fresenius Kabi Recent Development
Table 95. Hospira Company Details
Table 96. Hospira Description and Business Overview
Table 97. Hospira Oxaliplatin Product
Table 98. Hospira Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 99. Hospira Recent Development
Table 100. Mylan Company Details
Table 101. Mylan Oxaliplatin Product
Table 102. Mylan Description and Business Overview
Table 103. Mylan Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 104. Mylan Recent Development
Table 105. Jiangsu Hengrui Medicine Company Details
Table 106. Jiangsu Hengrui Medicine Oxaliplatin Product
Table 107. Jiangsu Hengrui Medicine Description and Business Overview
Table 108. Jiangsu Hengrui Medicine Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 109. Jiangsu Hengrui Medicine Recent Development
Table 110. Nanjing Pharmaceutical Factory Company Details
Table 111. Nanjing Pharmaceutical Factory Description and Business Overview
Table 112. Nanjing Pharmaceutical Factory Oxaliplatin Product
Table 113. Nanjing Pharmaceutical Factory Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 114. Nanjing Pharmaceutical Factory Recent Development
Table 115. Jiangsu Aosaikang Pharmaceutical Company Details
Table 116. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
Table 117. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product
Table 118. Jiangsu Aosaikang Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 119. Jiangsu Aosaikang Pharmaceutical Recent Development
Table 120. Qilu Pharmaceutical Company Details
Table 121. Qilu Pharmaceutical Description and Business Overview
Table 122. Qilu Pharmaceutical Oxaliplatin Product
Table 123. Qilu Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 124. Qilu Pharmaceutical Recent Development
Table 125. Hisun Pharmaceutical Company Details
Table 126. Hisun Pharmaceutical Description and Business Overview
Table 127. Hisun Pharmaceutical Oxaliplatin Product
Table 128. Hisun Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 129. Hisun Pharmaceutical Recent Development
Table 130. Lunan Pharmaceutical Company Details
Table 131. Lunan Pharmaceutical Description and Business Overview
Table 132. Lunan Pharmaceutical Oxaliplatin Product
Table 133. Lunan Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 134. Lunan Pharmaceutical Recent Development
Table 135. Luoxin Company Details
Table 136. Luoxin Description and Business Overview
Table 137. Luoxin Oxaliplatin Product
Table 138. Luoxin Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 139. Luoxin Recent Development
Table 140. Halfsky Pharmacy Company Details
Table 141. Halfsky Pharmacy Description and Business Overview
Table 142. Halfsky Pharmacy Oxaliplatin Product
Table 143. Halfsky Pharmacy Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 144. Halfsky Pharmacy Recent Development
Table 145. YRPG Company Details
Table 146. YRPG Description and Business Overview
Table 147. YRPG Oxaliplatin Product
Table 148. YRPG Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 149. YRPG Recent Development
Table 150. Hainan Jinrui Pharmaceutical Company Details
Table 151. Hainan Jinrui Pharmaceutical Description and Business Overview
Table 152. Hainan Jinrui Pharmaceutical Oxaliplatin Product
Table 153. Hainan Jinrui Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 154. Hainan Jinrui Pharmaceutical Recent Development
Table 155. Jari Pharmaceutical Company Details
Table 156. Jari Pharmaceutical Description and Business Overview
Table 157. Jari Pharmaceutical Oxaliplatin Product
Table 158. Jari Pharmaceutical Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 159. Jari Pharmaceutical Recent Development
Table 160. Chiatai Tianqing Company Details
Table 161. Chiatai Tianqing Description and Business Overview
Table 162. Chiatai Tianqing Oxaliplatin Product
Table 163. Chiatai Tianqing Revenue in Oxaliplatin Business (2018-2023) & (US$ Million)
Table 164. Chiatai Tianqing Recent Development
Table 165. Oxaliplatin Market Trends
Table 166. Oxaliplatin Market Drivers
Table 167. Oxaliplatin Market Challenges
Table 168. Oxaliplatin Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oxaliplatin Market Share by Type: 2022 VS 2029
Figure 2. Mannitol Features
Figure 3. Glucose Solution Features
Figure 4. Lactose Solution Features
Figure 5. Others Features
Figure 6. Global Oxaliplatin Market Share by Application: 2022 VS 2029
Figure 7. Colorectal Cancer Case Studies
Figure 8. Stomach Cancer Case Studies
Figure 9. Ovarian Cancer Case Studies
Figure 10. Others Case Studies
Figure 11. Oxaliplatin Report Years Considered
Figure 12. Global Oxaliplatin Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Oxaliplatin Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Oxaliplatin Revenue Market Share by Region: 2018 VS 2022
Figure 15. United States Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 16. Europe Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 17. China Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 18. Japan Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 19. Southeast Asia Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 20. India Oxaliplatin Revenue (Million USD) Growth Rate (2018-2029)
Figure 21. Global Oxaliplatin Market Share by Players in 2022
Figure 22. Global Top Oxaliplatin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxaliplatin as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Oxaliplatin Revenue in 2022
Figure 24. United States Oxaliplatin Market Share by Type (2018-2029)
Figure 25. United States Oxaliplatin Market Share by Application (2018-2029)
Figure 26. Europe Oxaliplatin Market Share by Type (2018-2029)
Figure 27. Europe Oxaliplatin Market Share by Application (2018-2029)
Figure 28. China Oxaliplatin Market Share by Type (2018-2029)
Figure 29. China Oxaliplatin Market Share by Application (2018-2029)
Figure 30. Japan Oxaliplatin Market Share by Type (2018-2029)
Figure 31. Japan Oxaliplatin Market Share by Application (2018-2029)
Figure 32. Southeast Asia Oxaliplatin Market Share by Type (2018-2029)
Figure 33. Southeast Asia Oxaliplatin Market Share by Application (2018-2029)
Figure 34. India Oxaliplatin Market Share by Type (2018-2029)
Figure 35. India Oxaliplatin Market Share by Application (2018-2029)
Figure 36. Sanofi-Aventis Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 37. Yakult honsha Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 38. Dr Reddy's laboratories Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 39. Sun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 40. Teva Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 41. Fresenius Kabi Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 42. Hospira Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 43. Mylan Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 44. Jiangsu Hengrui Medicine Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 45. Nanjing Pharmaceutical Factory Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 46. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 47. Qilu Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 48. Hisun Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 49. Lunan Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 50. Luoxin Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 51. Halfsky Pharmacy Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 52. YRPG Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 53. Hainan Jinrui Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 54. Jari Pharmaceutical Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 55. Chiatai Tianqing Revenue Growth Rate in Oxaliplatin Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs